Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat

Hypertension

Volumn 30, Issue 5, 1997, Pages 1232-1237

  Velasquez, Manuel T ^a   Striffler, John S ^b   Abraham, Andrew A ^b   Michaelis IV, Otho E ^b   Scalbert, Elizabeth ^b   Thibault, Nancy ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Angiotensin converting enzyme inhibition; Diabetes mellitus, non insulin dependent; Glomerulosclerosis; Proteinuria; Rats, inbred SHR; Renal tubulointerstitium

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; PERINDOPRIL; RENIN; RESERPINE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY INTERSTITIUM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030659651     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1232     Document Type: Article

References (45)

1. Mogensen CE. High blood pressure as a factor in the progression of diabetic nephropathy. Acta Med Scand Suppl. 1976;602:29-32.
2. Hasslacher CM, Stech W, Wahl PP, Ritz E. Blood pressure and metaboJic control as risk factors for nephropathy in Type I (insulin-dependent) diabetes. Diabetologia. 1985;28:6-11.
3. Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Chambelan M. Diabetic nephropathy: hemodynamic basis and implications for disease management. Ann Intern Med. 1989;110:795-813.
4. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest. 1976;36:383-388.
5. Christlieb AR, Warram JH, Krolewski AS, Busick EJ, Ganda OP, Asmal AC, Soeldner JS, Bradley RF. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes. 1981; 30(suppl 2):90-96.
6. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br J Med. 1982;285:685-688.
7. Parving H-H, Smidt UA, Andersen AR, Svendsen PA. Early aggressive antihypertensive treatment reduces rates of decline in kidney function in diabetic nephropathy. Lancet. 1983;1:1175-1179.
8. Viberti GC, Keen H, Wisemam MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J. 1987; 295:515-517.
9. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
10. + countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med. 1988;318:146-150.
11. Cooper ME, Allen TJ, Jerums G, Doyle AE. Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat. Clin Exp Pharmacol Physiol. 1986;13:655-662.
12. Cooper ME, Allen TJ, MacMillan P, Clarke B, O'Brien RC, Jerums G, Doyle AE. Effects of genetic hypertension on diabetic nephropathy in the rat. Functional and structural characteristics. J Hypertens. 1988;6:1009-1016.
13. Christensen CK, Mogensen CE. Antihypertensive treatment: long-term reversal of progression of proteinuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diab Compl. 1987;1:45-52.
14. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapv on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993;118:129-138.
15. Anderson S, Rennke HG, Garcia DL, Brenner BM. Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int. 1989;36:526-536.
16. Cooper ME, Allen TJ, O'Brien RC, Papazoglou D, Clarke BE, Jerums G, Doyle AE. Nephropathy in a model combining genetic hypertension with diabetes: enalapril vs hydralazine and metoprolol therapy. Diabetes. 1990;39:1575-1579.
17. Cooper ME, Rumble JR, Allen TJ, O'Brien RC, Jerums G, Doyle AE. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Kidney Int. 1992;41:898-903.
18. Gambaro G, Morbiato F, Cicerello E, Del Turco M, Sartori L, D'Angelo A, Grepaldi G. Captopril in the treatment of hypertension in type I and type II diabetic patients. J Hypertens. 1985; 3(suppl 2):153-154.
19. Baba T, Murabayashi S, Takabe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type II (non-insulin-dependent) diabetic patients with microalbuminuria: a randomized controlled trial. Diabetologia. 1989;32:40-44.
20. Bjork S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aerell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J. 1986;293:471-474.
21. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
22. Mulec H, Johnsen SA, Bjork S. Long-term enalapril treatment in diabetic nephropathy. Kidney Int. 1994;45(suppl. 45):S141-S144.
23. Hansen CT. Two congenie rat strains for nutrition and obesity research. Fed Proc. 1983;42:537.
24. Michaelis OE IV, Ellwood KC, Judge JM, Schoene NW, Hansen CT. Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes. Am J Clin Nutr. 1984;39:612-618.
25. Koletsky S. New type of spontaneously hypertensive rats with hyperlipemia and endocrine gland defects. In: Okamoto K, ed. Spontaneous Hypertension: Its Pathogenesis and Complications. Tokyo, Japan: Igaku Shoin Ltd; 1972:194-197.
26. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rat. Jpn Circ J. 1963;27:282-293.
27. Michaelis OE IV, Patrick DH, Hansen CT, Canary JJ, Werner RM, Carswell N. Spontaneous hypertensive/NIH-corpulent rat. Animal mode! for insulin-independent diabetes mellitus (type II). Am J Pathol. 1986;123:398-400.
28. Velasquez MT, Kimmel PL, Michaelis IV OE, Carswell N, Abraham A, Bosch JP. Effect of carbohydrate intake on kidney function and structure in SHR/N-cp rats. Diabetes. 1989;38:679-689.
29. Bunag RD. Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol. 1973;34:279-282.
30. Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from leuconostoc mesenteroides in the hexokinase method for determining glucose in the serum. Clin Chem. 1974;20:586-590.
31. Carswell N, Michaelis OE IV, Prather E. Effect of acarbose (BAY-g-5421) on expression of non-insulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats. J Nutr. 1989;119:383-394.
32. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969;29:1349-1355.
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RS. Protein measurement with the folinphenol reagent. J Biol Chem. 1951;123:265-275.
34. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:125-130.
35. O'Brien RC, Cooper ME, Jerums J, Doyle AE. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes. 1993;42:604-609.
36. Gellman DD, Pirani CL, Soothill JF, Muehrcke RC, Maduros W, Kark RM. Structure and function in diabetic nephropathy: the importance of diffuse glomerulosclerosis. Diabetes. 1959;8:251-2S6.
37. Mauer SM, Steffes MW, Michael AF, Brown DM. Studies of diabetic nephropathy in animals and man. 1976;25:850-857.
38. Osterby R, Gundersen HJG, Horilck A, Kroustrup JP, Nyberg G, Westberg G. Diabetic glomerulopathy: structural characteristics of the early and advanced stages. Diabetes. 1983;32:79-82.
39. Steffes MW, Mauer SM. Diabetic glomerulopathy in man and experimental animal models. Int Rev Exp Pathol. 1984;26:147-175.
40. O'Donnell MP, Kasiske BL, Keane WF. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 1988;2:2339-2347.
41. Bader R, Bader H, Grand KE, Mackensen-Haen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract. 1980;167:204-216.
42. Rasch P. Tubular lesions in streptozotocin diabetic rats. Diabetologia. 1984;27:32-37.
43. Deckert T, Parving H-H, Thomsen OF, Jorgensen HE, Brun C, Thomsen AC. Renal structure and function in type I (insulin-dependent) diabetic patients. Diabetic Nephropathy. 1985;4:163-168.
44. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest. 1984;74:1143-1155.
45. Ziyadeh FN, Goldfarb S. The renal tubulointerstitium in diabetes mellitus. Kidney Int. 1991;39:464-475.